您的位置: 首页 > 2017年1月 第48卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

46例直肠神经内分泌肿瘤临床病理特征分析

Clinicopathologic analysis of 46 cases of rectal neuroendocrine tumors

来源期刊: 广州医药 | 20-23 发布时间:2021-12-01 收稿时间:2025/11/13 17:15:01 阅读量:39
作者:
关键词:
直肠神经内分泌肿瘤临床病理特征病理分级
RectumNeuroendocrine tumorsPathologyPathological grading
DOI:
10.3969/j.issn.1000-8535.2017.01.005
收稿时间:
2016-10-20 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨直肠神经内分泌肿瘤的临床病理特征。方法 回顾性分析46例直肠神经内分泌肿瘤患者的临床病理资料,对不同病理分级的患者在性别、年龄、肿瘤直径、浸润深度、肝及淋巴结转移等方面进行比较。结果 直肠神经内分泌肿瘤男性多见,肿瘤多位于直肠中下段。免疫组化检测显示CgA、Syn、CD56阳性率分别为40.0%、97.8%、100%。36例Ki-67阳性指数≤2%,6例Ki-67阳性指数在3%~20%,4例Ki-67阳性指数>20%。不同病理分级的肿瘤与患者年龄、肿瘤直径、浸润深度、淋巴结及肝转移相关,与性别不相关。结论 直肠神经内分泌肿瘤缺乏临床特异性症状,联合CgA、Syn和CD56染色可提高直肠神经内分泌肿瘤的诊断率。病理分级对预测肿瘤浸润深度、肝或淋巴结转移有重要参考价值。
Objective To investigate the pathological and clinical significance of 46 cases of rectal neuroendocrine tumors(NET). Methods Retrospectively analyzed the clinical and pathological feature of 46 patients with rectal NET, and assessed possible interactions between different pathological grades and gender, age, tumor diameter, depth of invasion, lymph node and liver metastasis. Results Rectal NET appeared more frequently in males than in females. Most tumors located in middle and distal third of rectum. The positivity rates of immunohistochemical marker CgA, Syn, CD56 were 40.0%, 97.8%, 100.0%, respectively. The cases of Ki-67 positivity rate under 2%, ranged between 3%-20%, above 20% were 36, 6, 4, respectively. Different pathological grades were significantly correlated with age, tumor diameter, depth of invasion, lymph node and liver metastasis, but not with gender. Conclusion Rectal NET had nonspecific symptoms. Combined immunohistochemical staining, such as CgA, Syn and CD56, was important in the evaluation of rectal NET. Pathological grading might be very useful for prediction of invasion depth, lymph node and liver metastasis.
1、 CSCO神经内分泌肿瘤专家委员会. 中国胃肠胰神经内分泌肿瘤专家共识[J]. 临床肿瘤学杂志, 2013, 18(9):815-832. CSCO神经内分泌肿瘤专家委员会. 中国胃肠胰神经内分泌肿瘤专家共识[J]. 临床肿瘤学杂志, 2013, 18(9):815-832.
2、 来茂德. 胃肠胰神经内分泌肿瘤的认识和问题 [J]. 浙江大学学报(医学版), 2016, 45(1):9-23. 来茂德. 胃肠胰神经内分泌肿瘤的认识和问题 [J]. 浙江大学学报(医学版), 2016, 45(1):9-23.
3、 HOTTA K, SHIMODA T, NAKANISHI Y, et al. Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids [J]. Pathol Int, 2006, 56(10):591-596. HOTTA K, SHIMODA T, NAKANISHI Y, et al. Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids [J]. Pathol Int, 2006, 56(10):591-596.
4、 2013年中国胃肠胰神经内分泌肿瘤病理诊断共识专家组. 中国胃肠胰神经内分泌肿瘤病理诊断共识(2013版)[J]. 中华病理学杂志, 2013,42(10):6916-6994. 2013年中国胃肠胰神经内分泌肿瘤病理诊断共识专家组. 中国胃肠胰神经内分泌肿瘤病理诊断共识(2013版)[J]. 中华病理学杂志, 2013,42(10):6916-6994.
5、 HABAL N, SIMS C, BILCHIK A J. Gastrointestinal carcinoid tumors and second primary malignancies [J]. J Surg Oncol, 2000, 75(4):310-316. HABAL N, SIMS C, BILCHIK A J. Gastrointestinal carcinoid tumors and second primary malignancies [J]. J Surg Oncol, 2000, 75(4):310-316.
6、 TICHANSKY D S, CAGIR B, BORRAZZO E, et al. Risk of second cancers in patients with colorectal carcinoids [J]. Dis Colon Rectum, 2002, 45(1):91-97. TICHANSKY D S, CAGIR B, BORRAZZO E, et al. Risk of second cancers in patients with colorectal carcinoids [J]. Dis Colon Rectum, 2002, 45(1):91-97.
7、 LI A F, HSU C Y, LI A, et al. A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies [J]. Cancer, 2008, 112(2):274-283. LI A F, HSU C Y, LI A, et al. A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies [J]. Cancer, 2008, 112(2):274-283.
8、 MODLIN I M, LYE K D, KIDD M. A 5-decade analysis of 13,715 carcinoid tumors [J]. Cancer, 2003, 97(4):934-959. MODLIN I M, LYE K D, KIDD M. A 5-decade analysis of 13,715 carcinoid tumors [J]. Cancer, 2003, 97(4):934-959.
9、 JETMORE A B, RAY J E, GATHRIGHT JB JR, et al. Rectal carcinoids: the most frequent carcinoid tumor[J]. Dis Colon Rectum, 1992, 35(8):717-725. JETMORE A B, RAY J E, GATHRIGHT JB JR, et al. Rectal carcinoids: the most frequent carcinoid tumor[J]. Dis Colon Rectum, 1992, 35(8):717-725.
10、 DE HERDER W W, REHFELD J F, KIDD M, et al. A short history of neuroendocrine tumours and their peptide hormones [J]. Best Pract Res Clin Endocrinol Metab, 2015, 30(1):3-17. DE HERDER W W, REHFELD J F, KIDD M, et al. A short history of neuroendocrine tumours and their peptide hormones [J]. Best Pract Res Clin Endocrinol Metab, 2015, 30(1):3-17.
11、 HAMILTON S R, AALTONEN L A. World health organization classification of tumours, pathology and genetics of tumours of the digestive system[M]. Lyon: IARC Press, 2010, 137-139. HAMILTON S R, AALTONEN L A. World health organization classification of tumours, pathology and genetics of tumours of the digestive system[M]. Lyon: IARC Press, 2010, 137-139.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录